Organization · Private Equity
Ampersand Capital Partners
Ampersand Capital Partners is a private equity firm based in Boston, focusing on growth equity investments in the healthcare and life sciences sectors. It operates in North America, Europe, and the Asia-Pacific region.
Overview
What Ampersand Capital Partners does
What Ampersand Capital Partners is
Ampersand Capital Partners is a private equity firm based in Boston, focusing on growth equity investments in the healthcare and life sciences sectors. It operates in North America, Europe, and the Asia-Pacific region.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 1988
- Approximate age
- About 38 years
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Ampersand Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Ampersand Capital Partners as a funder
Investment thesis
Ampersand Capital Partners invests in lower to middle market healthcare companies, typically as the first institutional investor in founder-owned businesses. The firm targets companies with revenues between $10 million and $100 million and positive EBITDA.
Focus narrative
Ampersand Capital Partners invests in lower to middle market healthcare companies, typically as the first institutional investor in founder-owned businesses. The firm targets companies with revenues between $10 million and $100 million and positive EBITDA. Its investment strategy includes both minority and majority equity positions, focusing on key life sciences sub-segments such as laboratory products, laboratory services, contract manufacturing, pharma services, and specialty products.
Terms and economics
- Typical check
- $10,000,000–$100,000,000
Focus and fit
- Stages
- Growth Equity
- Regions
- AsiaEuropeNorth America
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Ampersand Capital Partners has a diverse portfolio that includes notable companies such as: Adaptas Solutions: Provides comprehensive sample-to-answer solutions for laboratory science and analytical equipment. Admera Health: Offers genomic and bioinformatic services for researchers in clinical and exploratory projects. Alcami: Engages in multi-phase pharmaceutical development and manufacturing for small and large molecules. Brammer Bio: Supplies clinical and commercial viral vectors for gene and cell therapies. Gannet BioChem: Specializes in the development and manufacturing of polyethylene glycol (PEG) reagents. Confluent Medical Technologies: Designs and develops manufacturing solutions for interventional catheter-based devices.
Common questions
What to know about Ampersand Capital Partners
Upseed classifies Ampersand Capital Partners under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.